| Returns | 1W : 28.7% , 1M : 21.3%,1Y : 59.6% |
| Peers & Returns | 1W | 1M | 1Y |
| DISHMAN CARBOGEN AMCIS | 28.7% | 21.3% | 59.6% |
| SUN PHARMACEUTICAL INDUSTRIES | 2.8% | 10.2% | 40.1% |
| DR REDDYS LABORATORIES | 7.8% | 18.3% | 26.4% |
| DIVIS LABORATORIES | 1.7% | 12% | 63.2% |
| CIPLA | 7.2% | 22.8% | 58.3% |
| BIOCON | -1.4% | 3.4% | 14.3% |
| AUROBINDO PHARMA | 8.5% | 17.7% | 77.9% |
| LUPIN | 5.1% | 6.9% | 28.9% |
| TORRENT PHARMACEUTICALS | 1.5% | 7.8% | 15.5% |
| Ratio | Value |
|---|---|
|
P/E P/B P/S |
12.72
P/E Calculated based on EPS of 11.49
[ Mar2020 - Consolidated Results ] 0.4
P/B Calculated based on Book Value of 365.69
[ Mar2020 - Consolidated Results ] 1.15
P/S Calculated based on Revenues of 1996.12 Cr
[ TTM - Consolidated Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
-17% -53% -30% |
| Pledged Shares |
0 % |
|---|---|
| As on : Sep2020 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE HEALTHCARE | 4.4% | 13% | 55.2% |
| S&P BSE SMALL CAP | -0.1% | 0.3% | 91.4% |
| S&P BSE MIDSMALLCAP | -0.3% | -0.3% | 79.7% |
| S&P BSE 400 MIDSMALLCAP | -0.4% | -0.8% | 81% |
| S&P BSE 250 SMALLCAP | -1% | -2.2% | 88.2% |
| S&P BSE ALLCAP | -1.1% | -2.1% | 60% |
| S&P BSE 500 | -1.1% | -2.2% | 59.1% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY MID SMALL400 | -0.7% | -1% | 81% |
| NIFTY SMALLCAP250 | -0.7% | -1.2% | 90.7% |
| NIFTY 500 | -1.1% | -2.2% | 58.6% |
